Cargando…

Anticoagulation for atrial fibrillation in active cancer

Atrial fibrillation (AF) may often pre-exist in patients with newly diagnosed cancer or occur with increased frequency shortly after cancer diagnosis. Patients with active cancer and AF have a particularly high risk of thromboembolic complications, as both conditions carry a risk of thrombosis. Thro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farmakis, Dimitrios, Papakotoulas, Pavlos, Angelopoulou, Eleni, Bischiniotis, Theodoros, Giannakoulas, George, Kliridis, Panagiotis, Richter, Dimitrios, Paraskevaidis, Ioannis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867206/ https://www.ncbi.nlm.nih.gov/pubmed/35261638 http://dx.doi.org/10.3892/ol.2022.13244

Ejemplares similares

Opposite relations of epicardial adipose tissue to left atrial size in paroxysmal and permanent atrial fibrillation
por: Psychari, Stavroula N, et al.
Publicado: (2018)

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
por: Tiili, Paula, et al.
Publicado: (2021)

Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
por: Samaras, Athanasios, et al.
Publicado: (2021)

Inflammation and Heart Failure: Searching for the Enemy—Reaching the Entelechy
por: Paraskevaidis, Ioannis, et al.
Publicado: (2023)

Management of COVID-19 in Patients with Pulmonary Arterial Hypertension
por: Farmakis, Ioannis T., et al.
Publicado: (2023)

Echocardiography in Pulmonary Arterial Hypertension: Is It Time to Reconsider Its Prognostic Utility?
por: Farmakis, Ioannis T., et al.
Publicado: (2021)

Anticoagulation in patients with atrial fibrillation and liver cirrhosis
por: Karapedi, Eleni, et al.
Publicado: (2022)

Prognostic significance of diabetes mellitus in patients with atrial fibrillation
por: Papazoglou, Andreas S., et al.
Publicado: (2021)

Epicardial Adipose Tissue and Atrial Fibrillation Recurrence following Catheter Ablation: A Systematic Review and Meta-Analysis
por: Anagnostopoulos, Ioannis, et al.
Publicado: (2023)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Oral Anticoagulants for Atrial Fibrillation Patients with Active Cancer
por: Kim, Do Young, et al.
Publicado: (2018)

Oral Anticoagulants in Japanese Patients with Atrial Fibrillation and Active Cancer
por: Yasui, Taku, et al.
Publicado: (2019)

Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation
por: Papazoglou, Andreas S., et al.
Publicado: (2022)

Changes in CHA(2)DS(2)-VASc score and risk of ischemic stroke among patients with atrial fibrillation
por: Tsiartas, Eirinaios, et al.
Publicado: (2023)

Τhe association of heart failure across left ventricular ejection fraction with mortality in atrial fibrillation
por: Kartas, Anastasios, et al.
Publicado: (2021)

A New Hope: Sodium-Glucose Cotransporter-2 Inhibition to Prevent Atrial Fibrillation
por: Karamichalakis, Nikolaos, et al.
Publicado: (2022)

Ibutilide for the Cardioversion of Paroxysmal Atrial Fibrillation during Radiofrequency Ablation of Supraventricular Tachycardias
por: Polymeropoulos, Kostas, et al.
Publicado: (2011)

Anticoagulation for atrial fibrillation in heart failure patients: balancing between Scylla and Charybdis
por: Tsigkas, Grigorios, et al.
Publicado: (2021)

Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks
por: Atterman, Adriano, et al.
Publicado: (2021)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Anticoagulation in atrial fibrillation: the present and the future
por: Dweck, Marc R, et al.
Publicado: (2012)

Patterns of Anticoagulation Use in Patients With Cancer With Atrial Fibrillation and/or Atrial Flutter
por: Fradley, Michael G., et al.
Publicado: (2020)

Anticoagulation in Cancer Patients With Atrial Fibrillation or Atrial Flutter: Are There Gaps in Care?
por: Russo, Andrea M.
Publicado: (2020)

Hematuria in anticoagulated patients with atrial fibrillation and urologic cancer
por: Ording, Anne Gulbech, et al.
Publicado: (2022)

Cardioselective versus Non-Cardioselective Beta-Blockers and Outcomes in Patients with Atrial Fibrillation and Chronic Obstructive Pulmonary Disease
por: Vlachopoulou, Dimitra, et al.
Publicado: (2023)

Laboratory Assessment of the Anticoagulant Activity of Apixaban in Patients With Nonvalvular Atrial Fibrillation
por: Kyriakou, Elias, et al.
Publicado: (2018)

Oral Anticoagulation in Patients With Atrial High-Rate Episodes: Focus on Clinical Implications
por: Dimou, Smaro, et al.
Publicado: (2023)

Intraoperative tracheal reconstruction with bovine pericardial patch following iatrogenic rupture
por: Barbetakis, Nikolaos, et al.
Publicado: (2008)

Outcomes by Class of Anticoagulant Use for Nonvalvular Atrial Fibrillation in Patients With Active Cancer
por: Potter, Adam S., et al.
Publicado: (2022)

Atrial Fibrillation Ablation without Interruption of Anticoagulation
por: Santangeli, Pasquale, et al.
Publicado: (2011)

The new oral anticoagulants in atrial fibrillation: an update
por: Verheugt, F. W. A.
Publicado: (2013)

Newer Anticoagulants for Non-Valvular Atrial Fibrillation
por: Harburger, Joseph M., et al.
Publicado: (2012)

MRI Screening for Chronic Anticoagulation in Atrial Fibrillation
por: Fisher, Mark
Publicado: (2013)

Satisfaction with oral anticoagulants in patients with atrial fibrillation
por: Suárez Fernández, Carmen, et al.
Publicado: (2018)

Anticoagulant Therapy for Frail Patients with Atrial Fibrillation
por: Hori, Hiroshi, et al.
Publicado: (2021)

Secondary Precipitants of Atrial Fibrillation and Anticoagulation Therapy
por: Ko, Darae, et al.
Publicado: (2021)

Direct Oral Anticoagulants in Patients With Cancer and Nonvalvular Atrial Fibrillation
por: Davis, Margot K., et al.
Publicado: (2021)

Box Lesion Isolation of the Left Atrial Posterior Wall with Radiofrequency Ablation Restricted in Predetermined Lines for the Treatment of Persistent Atrial Fibrillation: The Prognostic Role of Acute Interventional Outcome and Trigger Identification
por: Ioannidis, Panagiotis, et al.
Publicado: (2023)

Temporal trends in the efficacy of revascularization in stable ischaemic heart disease: A cumulative meta-analysis
por: Farmakis, Ioannis T., et al.
Publicado: (2022)

Comparative efficacy and safety of oral P2Y(12) inhibitors after non-ST-elevation acute coronary syndromes: a network meta-analysis
por: Farmakis, Ioannis T, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ugs65nnfvsdam5c1j2kkp6l41b